Thanks, Senti. I think it would be of immense value to the shareholders if the journal article incorporates the guidance for external control arm usage provided in the FDA journal paper. Imo, LL and her team may already have accomplished this to strengthen an already peer-reviewed paper. The authors are at liberty to add to their paper before final acceptance.
Market Data 
Markets 
AI
